Navigation Links
Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths,,

Baycol is a prescription drug manufactured by Bayer Pharmaceuticals. Baycol, which was initially approved by the FDA, belongs to a statin group of drugs that lowers cholesterol by blocking enzymes that are essential in the synthesis of cholesterol in the body.

Bayer Pharmaceuticals has voluntarily recalled its cholesterol drug Baycol( cerivastatin ) because // it has been linked to approximately 50 deaths. Baycol can cause a muscular side effect called rhabdomyolysis – destroyed muscles cells are released into the bloodstream and cause severe muscle pain, fever, weakness and vomiting. This condition can also lead to kidney failure.

The FDA said fatal reports with Baycol had been reported most frequently when the drug was used at higher doses, in elderly patients, and especially when taken in combination with another cholesterol-lowering drug called gemfibrozil. It said patients taking Baycol should consult their physicians about switching to another medication to control their cholesterol agents. Pharmacies will be instructed to return the product to the manufacturer for a refund.

FDA announced that Bayer Pharmaceutical Division is voluntarily withdrawing Baycol from the U.S. market. Patients who are taking Baycol should discontinue Baycol and consult their physicians about switching to alternate medications to control their cholesterol levels.


'"/>




Page: 1

Related medicine news :

1. Bayer Wins Positive Response For Marketing Its Cancer Drug
2. Genomatix Licensed By Bayer Healthcare
3. Bayer to Market Biocon Insulin in China
4. Test for Esophageal Reflux Licensed to Bayer by University
5. Hospital Withdraws McDonalds Reward Scheme
6. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
7. Associated therapy for multiple myeloma
8. Associated scan for detecting ovarian cancer spread
9. Ginseng Associated with Pregnancy Risks
10. Enzyme Associated with Memory
11. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: